Lilly Eli & Co

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Lilly Eli & Co
TickerLLY
CIK #0000059478
CUSIP532457108
SectorLife Sciences - Pharmaceutical Preparations
AddressLilly Corporate Ctr Drop Code 1112, Indianapolis, IN 46285
Source [EDGAR]
CIK Filing 2011 - 2025
[0000059478] 10-K
[0000059478] 10-Q
[0000059478] 3
[0000059478] 4
[0000059478] 5
[0000059478] 8-K
[0000059478] SC 13D
[0000059478] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Eli Lilly & Co Sigilon Therapeutics Inc [2023-07-07] 40.3
Eli Lilly & Co Akouos Inc [2022-10-27] 25.5
Eli Lilly & Co Immunocore Holdings PLC [2022-02-10] 5.8
Eli Lilly & Co Foghorn Therapeutics Inc [2021-12-13] 0.7
Eli Lilly & Co Proqr Therapeutics NV [2021-09-10] 5.6
Eli Lilly & Co AC Immune Sa [2021-02-12] 5.0
Eli Lilly & Co Sigilon Therapeutics Inc [2021-02-12] 8.8
Eli Lilly & Co Avidity Biosciences Inc [2021-02-12] 6.2
Eli Lilly & Co Precision Biosciences Inc [2021-01-08] 7.165
Eli Lilly & Co Prevail Therapeutics Inc [2020-12-22] 53.3
PNC Financial Services Group Inc Eli Lilly & Co [2020-02-14] 5.43
Eli Lilly & Co Dermira Inc [2020-01-10] 12.9
Lilly Eli & Co Elanco Animal Health Inc [2019-02-14] 80.2
Lilly Eli & Co Loxo Oncology Inc [2019-01-15] 6.6
Lilly Eli & Co Dicerna Pharmaceuticals Inc [2018-12-20] 8.6
Lilly Eli & Co Zymeworks Inc [2018-02-14] 15.6
Lilly Eli & Co LEAP Therapeutics Inc [2017-11-22] 17.5
Wellington Management Group LLP Lilly Eli & Co [2017-02-09] 5.15
Lilly Eli & Co Colucid Pharmaceuticals Inc [2017-01-27] 35.0
Lilly Eli & Co Lilly Eli & Co [2016-04-22] 19.2
Vanguard Group Inc Lilly Eli & Co [2016-02-11] 5.4
Lilly Eli & Co Ignyta Inc [2015-11-16] 8.4
Lilly Eli & Co Cerulean Pharma Inc [2015-02-17] 11.7
Lilly Eli & Co Zosano Pharma Corp [2015-02-09] 11.5
Lilly Eli & Co Coherus Biosciences Inc [2014-11-24] 0.1
PRIMECAP Management Co/CA/ Lilly Eli & Co [2014-03-07] 5.0
Wellington Management Co LLP Lilly Eli & Co [2014-02-14] 5.64
Form 3/4/5 Filer 2011 - 2025
ELI LILLY & Co
Luciano Juan R
Hedley Mary Lynne
Fyrwald J Erik
Alvarez Ralph
Sulzberger Gabrielle
Montarce Lucas
Van Naarden Jacob
Yuffa Ilya
Skovronsky Daniel
Ricks David A
Jackson Jamere
Seymour Melissa
Lilly Endowment Inc
Custer Kenneth L.
Zakrowski Donald A
Hakim Anat
Hernandez Edgardo
Dozier Eric
White Anne E.
Rau Diogo
Jonsson Patrik
Johnson Kimberly H
Moeller Jon R
Baicker Katherine
Walker Karen
Kaelin William G Jr
Brooks Gordon J.
Norton Johna
Ashkenazi Anat
Weems Alonzo
Runge Marschall S
Shenandoah Acquisition Corp
Sigilon Therapeutics, Inc.
Tai Jackson P
Mason Michael B
Pusey Leigh Ann
Kearny Acquisition Corp
Akouos, Inc.
Fry Stephen F
Eskew Michael L
Zulueta Alfonso G
Smiley Joshua L
Shah Aarti S.
O'Neill Myles
Barnes Melissa S
Tyto Acquisition Corp
Prevail Therapeutics Inc.
Seifert Kathi P
Bertozzi Carolyn R
Avidity Biosciences, Inc.
Dermira, Inc.
Bald Eagle Acquisition Corp
Harrington Michael J
Shaw Christi
Marram Ellen R
Elanco Animal Health Inc
Conterno Enrique A
Zymeworks BC Inc.
Simmons Jeffrey N
LEAP Therapeutics Inc
Mahony Susan
Lundberg Jan M
Crowe Maria A
Rice Derica W
Lechleiter John C
Hoover R David
Prendergast Franklyn G
CoLucid Pharmaceuticals, Inc.
ProCar Acquisition Corp
Peterson Barton R
Walsh Fionnuala M
Spyre Therapeutics, Inc.
Horn Karen N
Zosano Pharma Corp
Oberhelman Douglas R
Lilly Ventures Fund I LLC
Coherus Oncology, Inc.
Dare Bioscience, Inc.
Tapiero Jacques
Bischoff Winfried F W Sir
Gilman Alfred G
Armitage Robert A
Nobles Anne
Hanish Arnold C
Carmine Bryce D.
Deane Frank M
Form 13F Holdings
Firm Period DFND Voting Shares
Lilly Endowment Inc [2025-06-30] SOLE 96,016,978 96,016,978
Vanguard Group Inc [2025-06-30] SOLE 0 76,528,771
BlackRock, Inc. [2025-06-30] SOLE 59,449,406 66,056,006
PNC Financial Services Group Inc [2025-06-30] DFND 1,050,029 51,077,044
State Street Corp [2025-06-30] DFND 20,243,112 34,506,968
FMR LLC [2025-06-30] DFND 23,392,767 25,629,773
Capital Research Global Investors [2025-06-30] DFND 20,746,317 20,756,363
Geode Capital Management LLC [2025-06-30] DFND 18,111,024 18,128,627
Capital World Investors [2025-06-30] DFND 17,581,381 17,634,492
Morgan Stanley [2025-06-30] DFND 7,269,733 14,868,496
Wellington Management Group LLP [2025-06-30] DFND 0 13,989,551
JPMorgan Chase & Co [2025-06-30] DFND 10,238,788 12,445,168
Bank of America Corp /DE/ [2025-06-30] DFND 1,419,130 12,185,666
PRIMECAP Management Co/CA/ [2025-06-30] SOLE 11,913,931 12,154,908
Norges Bank [2025-06-30] SOLE 11,324,406 11,324,406
Capital International Investors [2025-06-30] DFND 9,397,273 9,422,128
State Farm Mutual Automobile Insurance Co [2025-06-30] SOLE 9,090,106 9,090,106
Northern Trust Corp [2025-06-30] DFND 8,268,045 8,470,594
Susquehanna International Group LLP [2025-06-30] OTR 212,045 6,720,745
Citadel Advisors LLC [2025-06-30] DFND 6,313,252 6,313,252
Goldman Sachs Group Inc [2025-06-30] DFND 5,212,446 5,916,611
Nuveen, LLC [2025-06-30] DFND 5,663,174 5,689,733
Charles Schwab Investment Management Inc [2025-06-30] SOLE 5,359,427 5,359,653
Jennison Associates LLC [2025-06-30] DFND 4,868,922 5,322,707
Legal & General Group Plc [2025-06-30] DFND 4,786,182 5,229,285
AllianceBernstein LP [2025-06-30] DFND 4,867,494 5,213,854
Bank of New York Mellon Corp [2025-06-30] DFND 3,995,713 5,095,401
Franklin Resources Inc [2025-06-30] DFND 4,706,978 4,765,662
UBS Group AG [2025-06-30] DFND 1,828,795 4,528,046
Janus Henderson Group PLC [2025-06-30] DFND 0 4,384,862
Prev | Page 1 | Next
Terms | Privacy | Guide
tony@aum13f.com